<!DOCTYPE html>
<html>

    <head>
        <title>Blank Page</title>
        <meta name="viewport" content="width=device-width, initial-scale=1.0">
        
    </head>
    <body>
     <div class="content">
<p style="text-align:justify" tabindex="0"><span style="font-size:14px">The recent study conducted by Rothenb&uuml;hler <em>et al</em>., examined the global prevalence of RHD. In order to estimate the combined prevalence of rheumatic heart disease within endemic countries, the systematic review examined population-based studies from the regions of Asia, Africa, Oceania, Latin-America and Europe. Various meta-analyses were performed to explore the effect of screening modality, geography, and age, on the pooled prevalence estimates. The prevalence of clinically silent RHD was estimated to be 7 to 8 times more prevalent than clinically manifest disease, with globally pooled prevalence rates of 21.1 per 1,000 (95% CI 14.1 to 31.4) and 2.7 per 1,000 (95% CI 1.6 to 4.4), respectively.<strong><sup> </sup></strong></span></p>


<p class="MsoNormal" style="text-align:justify" tabindex="0"><span style="font-size:14px"><u>Study inclusion criteria:</u></span></p>
<ul tabindex="0">
	<li class="MsoListParagraphCxSpFirst" style="text-align:justify"><span style="font-size:14px">Population-based design</span></li>
	<li class="MsoListParagraphCxSpFirst" style="text-align:justify"><span style="font-size:14px">Sample size of at least 500</span></li>
	<li class="MsoListParagraphCxSpMiddle" style="text-align:justify"><span style="font-size:14px">Inclusion of children at least 5 years old and adolescents younger than 18 years old</span></li>
	<li class="MsoListParagraphCxSpMiddle" style="text-align:justify"><span style="font-size:14px">Reporting on the prevalence of RHD</span></li>
</ul>


<p tabindex="0"><span style="font-size:14px"><u>Definitions used in the review:</u></span></p>

<p class="MsoNormal" style="text-align:justify" tabindex="0"><span style="font-size:14px"><em>Prevalence of Rheumatic Heart Disease: </em></span>

<span style="font-size:14px">&ldquo;Total burden of valvular lesions consistent with RHD in a specified population.&rdquo;</span></p>

<p class="MsoNormal" style="text-align:justify" tabindex="0"><span style="font-size:14px"><em>Clinically manifest RHD: </em></span>

<span style="font-size:14px">&ldquo;Presence of a heart murmur on cardiac auscultation, consistent with echocardiographic evidence.&rdquo;</span></p>


<p class="MsoNormal" style="text-align:justify" tabindex="0"><span style="font-size:14px"><em>Clinically silent RHD: </em></span>

<span style="font-size:14px">&ldquo;Pathological regurgitation or mitral stenosis, or detection of morphological changes, or both, consistent with RHD in the absence of a heart murmur.&rdquo;</span></p>

<p tabindex="0"><span style="font-size:12px"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25433627" target="_blank">Reference:</a> Rothenb&uuml;hler, M., O&#39;Sullivan, C. J., Stortecky, S., Stefanini, G. G., Spitzer, E., Estill, J., Pilgrim, T. (2014). Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents. Lancet Glob Health, 2(12), e717-726. doi: 10.1016/s2214-109x(14)70310-9</span></p>
</div>
        
    </body>
</html>
